{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:52:48Z","timestamp":1787734368118,"version":"build-2784847793"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10072-020-04341-5","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T03:02:36Z","timestamp":1585364556000},"page":"1931-1933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autosomal dominant SPG9: intrafamilial variability and onset during pregnancy"],"prefix":"10.1007","volume":"41","author":[{"given":"C.","family":"Marelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Badiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Genestet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Larrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Damier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Camu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Planes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Guissart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,28]]},"reference":[{"key":"4341_CR1","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.1074\/jbc.274.10.6754","volume":"274","author":"CA Hu","year":"1999","unstructured":"Hu CA, Lin WW, Obie C, Valle D (1999) Molecular enzymology of mammalian delta1-pyrroline-5-carboxylate synthase. Alternative splice donor utilization generates isoforms with different sensitivity to ornithine inhibition. J Biol Chem 274:6754\u20136762","journal-title":"J Biol Chem"},{"key":"4341_CR2","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1093\/hmg\/9.19.2853","volume":"9","author":"MR Baumgartner","year":"2000","unstructured":"Baumgartner MR, Hu CA, Almashanu S et al (2000) Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. Hum Mol Genet 9:2853\u20132858","journal-title":"Hum Mol Genet"},{"key":"4341_CR3","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/brain\/awv143","volume":"138","author":"M Coutelier","year":"2015","unstructured":"Coutelier M, Goizet C, Durr A, Habarou F, Morais S, Dionne-Laporte A, Tao F, Konop J, Stoll M, Charles P, Jacoupy M, Matusiak R, Alonso I, Tallaksen C, Mairey M, Kennerson M, Gaussen M, Schule R, Janin M, Morice-Picard F, Durand CM, Depienne C, Calvas P, Coutinho P, Saudubray JM, Rouleau G, Brice A, Nicholson G, Darios F, Loureiro JL, Zuchner S, Ottolenghi C, Mochel F, Stevanin G (2015) Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. Brain J Neurol 138:2191\u20132205. https:\/\/doi.org\/10.1093\/brain\/awv143","journal-title":"Brain J Neurol"},{"key":"4341_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/(SICI)1096-8628(19960301)62:1<42::AID-AJMG9>3.0.CO;2-Y","volume":"62","author":"AM Slavotinek","year":"1996","unstructured":"Slavotinek AM, Pike M, Mills K, Hurst JA (1996) Cataracts, motor system disorder, short stature, learning difficulties, and skeletal abnormalities: a new syndrome? Am J Med Genet 62:42\u201347. https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19960301)62:1<42::AID-AJMG9>3.0.CO;2-Y","journal-title":"Am J Med Genet"},{"key":"4341_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1086\/302241","volume":"64","author":"M Seri","year":"1999","unstructured":"Seri M, Cusano R, Forabosco P, Cinti R, Caroli F, Picco P, Bini R, Morra VB, de Michele G, Lerone M, Silengo M, Pela I, Borrone C, Romeo G, Devoto M (1999) Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. Am J Hum Genet 64:586\u2013593. https:\/\/doi.org\/10.1086\/302241","journal-title":"Am J Hum Genet"},{"key":"4341_CR6","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1093\/brain\/awv247","volume":"139","author":"E Panza","year":"2016","unstructured":"Panza E, Escamilla-Honrubia JM, Marco-Mar\u00edn C et al (2016) ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism. Brain J Neurol 139:e3. https:\/\/doi.org\/10.1093\/brain\/awv247","journal-title":"Brain J Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04341-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-020-04341-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04341-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:21:06Z","timestamp":1616890866000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-020-04341-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,28]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["4341"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04341-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,28]]},"assertion":[{"value":"7 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CM received honorary travel to attend scientific meetings from Biomarin and Actelion Pharmaceuticals and honorary for consultant activity (Biomarin); SB, SG, LL, WC, MP, MK, and CG have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The paper was written in accordance with the Helsinki Declaration (2013). A written consentement for genetic analysis and research was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}